{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T02:24:56Z","timestamp":1774146296890,"version":"3.50.1"},"reference-count":197,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Cardiogenic shock (CS) is a hemodynamically complex and highly morbid syndrome characterized by circulatory collapse and inadequate end-organ perfusion due to impaired cardiac output. It is usually associated with multiorgan failure and death. Mortality rate is still high despite advancement in treatment. CS has been conceptualised as a vicious cycle of injury and decompensation, both cardiac and systemic. Interrupting the vicious cycle and restoring the hemodynamic stability is a fundamental treatment of CS. Acute coronary syndrome (ACS) is the most frequent cause of CS. Early coronary revascularization is a cornerstone therapy that reduces mortality in patients with ACS complicated by CS. Early diagnosis of CS accompanied with invasive hemodynamics, helps in identification of CS phenotype, classification of CS severity, stratification of risk and prognostication. This can guide a tailored and optimized therapeutic approach. Inotropes and vasopressors are considered the first-line pharmacological option for hemodynamic instability. The current availability of the mechanical circulatory support devices has broadened the therapeutic choices for hemodynamic support. To date there is no pharmacological or nonpharmacological intervention for CS that showed a mortality benefit. The clinical practices in CS management remain inconsistent. Herein, this review discusses the current evidence in the diagnosis and management of CS complicating ACS, and features the changes in CS definition and classification.<\/jats:p>","DOI":"10.31083\/j.rcm2203078","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T02:35:45Z","timestamp":1632623745000},"source":"Crossref","is-referenced-by-count":14,"title":["Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome"],"prefix":"10.31083","volume":"22","author":[{"given":"Rasha","family":"Kaddoura","sequence":"first","affiliation":[{"name":"Pharmacy Department, Heart Hospital, Hamad Medical Corporation, 3050 Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah","family":"Elbdri","sequence":"first","affiliation":[{"name":"Cardiology Department, Heart Hospital, Hamad Medical Corporation, 3050 Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Vincent J, De Backer D. Circulatory Shock. New England Journal of Medicine. 2013; 369: 1726\u20131734.","DOI":"10.1056\/NEJMra1208943"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Zeymer U, Bueno H, Granger CB, Hochman J, Huber K, Lettino M, et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology. European Heart Journal. 2020; 9: 183\u2013197.","DOI":"10.1177\/2048872619894254"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of Cardiogenic Shock: a Scientific Statement from the American Heart Association. Circulation. 2017; 136: e232\u2013e268.","DOI":"10.1161\/CIR.0000000000000525"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, et al. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. JACC: Heart Failure. 2020; 8: 879\u2013891.","DOI":"10.1016\/j.jchf.2020.09.005"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Harjola V, Lassus J, Sionis A, K\u00f8ber L, Tarvasm\u00e4ki T, Spinar J, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. European Journal of Heart Failure. 2015; 17: 501\u2013509.","DOI":"10.1002\/ejhf.260"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Holmes DR, Bates ER, Kleiman NS, Sadowski Z, Horgan JHS, Morris DC, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Journal of the American College of Cardiology. 1995; 26: 668\u2013674.","DOI":"10.1016\/0735-1097(95)00215-P"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Holmes DR, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation. 1999; 100: 2067\u20132073.","DOI":"10.1161\/01.CIR.100.20.2067"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Anderson ML, Peterson ED, Peng SA, Wang TY, Ohman EM, Bhatt DL, et al. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: a report from NCDR. Circulation. Cardiovascular Quality and Outcomes. 2013; 6: 708\u2013715.","DOI":"10.1161\/CIRCOUTCOMES.113.000262"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Hasdai D, Harrington RA, Hochman JS, Califf RM, Battler A, Box JW, et al. Platelet glycoprotein IIb\/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. Journal of the American College of Cardiology. 2000; 36: 685\u2013692.","DOI":"10.1016\/S0735-1097(00)00814-7"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kolte D, Khera S, Dabhadkar KC, Agarwal S, Aronow WS, Timmermans R, et al. Trends in Coronary Angiography, Revascularization, and Outcomes of Cardiogenic Shock Complicating Non-ST-Elevation Myocardial Infarction. American Journal of Cardiology. 2016; 117: 1\u20139.","DOI":"10.1016\/j.amjcard.2015.10.006"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Journal of the American Medical Association. 2005; 294: 448\u2013454.","DOI":"10.1001\/jama.294.4.448"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Webb JG, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. should we emergently revascularize Occluded Coronaries for cardiogenic shocK? Journal of the American College of Cardiology. 2000; 36: 1084\u20131090.","DOI":"10.1016\/S0735-1097(00)00876-7"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheterization and Cardiovascular Interventions. 2019; 94: 29\u201337.","DOI":"10.1002\/ccd.28329"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Agress CM, Binder MJ. Cardiogenic shock. American Heart Journal. 1957; 54: 458\u2013477.","DOI":"10.1016\/0002-8703(57)90136-9"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Ginsberg F, Parrillo JE. Cardiogenic shock: a historical perspective. Critical Care Clinics. 2009; 25: 103\u201314, viii.","DOI":"10.1016\/j.ccc.2008.12.005"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Malach M, Rosenberg BA. Acute myocardial infarction in a city hospital. III. Experience with shock. American Journal of Cardiology. 1960; 5: 487\u2013492.","DOI":"10.1016\/0002-9149(60)90106-5"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Weisse AB. The elusive clot: the controversy over coronary thrombosis in myocardial infarction. Journal of the History of Medicine and Allied Sciences. 2006; 61: 66\u201378.","DOI":"10.1093\/jhmas\/jrj003"},{"key":"ref18","unstructured":"Alves J, Saddala P, Maddaleni M. Cardiogenic shock historical perspective. 2014. Available at: https:\/\/www.wikidoc.org\/index.php\/Cardiogenic_shock_historical_perspective (Accessed: 18 May 2021)."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Scholz KH, Maier SKG, Maier LS, Lengenfelder B, Jacobshagen C, Jung J, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. European Heart Journal. 2018; 39: 1065\u20131074.","DOI":"10.1093\/eurheartj\/ehy004"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Backhaus T, Fach A, Schmucker J, Fiehn E, Garstka D, Stehmeier J, et al. Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry. Clinical Research in Cardiology. 2018; 107: 371\u2013379.","DOI":"10.1007\/s00392-017-1192-0"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. should we Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. New England Journal of Medicine. 1999; 341: 625\u2013634.","DOI":"10.1056\/NEJM199908263410901"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, et al. Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative. Catheterization and Cardiovascular Interventions. 2019; 93: 1173\u20131183.","DOI":"10.1002\/ccd.28307"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Bellumkonda L, Gul B, Masri SC. Evolving Concepts in Diagnosis and Management of Cardiogenic Shock. American Journal of Cardiology. 2018; 122: 1104\u20131110.","DOI":"10.1016\/j.amjcard.2018.05.040"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Griffith GC, Wallace WB, Cochran B, Nerlich WE, Frasher WE. The treatment of shock associated with myocardial infarction. Circulation. 1954; 9: 527\u2013532.","DOI":"10.1161\/01.CIR.9.4.527"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hunt D, Sloman G, Christie D, Penington C. Changing patterns and mortality of acute myocardial infarction in a coronary care unit. British Medical Journal. 1977; 1: 795\u2013798.","DOI":"10.1136\/bmj.1.6064.795"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. American Journal of Cardiology. 1967; 20: 457\u2013464.","DOI":"10.1016\/0002-9149(67)90023-9"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. New England Journal of Medicine. 1991; 325: 1117\u20131122.","DOI":"10.1056\/NEJM199110173251601"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O\u2019Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation. 1988; 78: 1345\u20131351.","DOI":"10.1161\/01.CIR.78.6.1345"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction. New England Journal of Medicine. 1999; 340: 1162\u20131168.","DOI":"10.1056\/NEJM199904153401504"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated with Cardiogenic Shock in Patients with Acute Myocardial Infarction. Circulation. 2009; 119: 1211\u20131219.","DOI":"10.1161\/CIRCULATIONAHA.108.814947"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New England Journal of Medicine. 1993; 329: 673\u2013682.","DOI":"10.1056\/NEJM199309023291001"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation. 1995; 91: 873\u2013881.","DOI":"10.1161\/01.CIR.91.3.873"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, et al. Cardiogenic shock complicating acute myocardial infarction\u2013etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenic shocK? Journal of the American College of Cardiology. 2000; 36: 1063\u20131070.","DOI":"10.1016\/S0735-1097(00)00879-2"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Goldberg RJ, Gore JM, Thompson CA, Gurwitz JH. Recent magnitude of and temporal trends (1994\u20131997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. American Heart Journal. 2001; 141: 65\u201372.","DOI":"10.1067\/mhj.2001.111405"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, et al. Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: a Report from the CathPCI Registry. JACC. Cardiovascular Interventions. 2016; 9: 341\u2013351.","DOI":"10.1016\/j.jcin.2015.10.039"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJS, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock after Acute Myocardial Infarction. Journal of the American College of Cardiology. 2017; 69: 278\u2013287.","DOI":"10.1016\/j.jacc.2016.10.022"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Seyfarth M, Sibbing D, Bauer I, Fr\u00f6hlich G, Bott-Fl\u00fcgel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. Journal of the American College of Cardiology. 2008; 52: 1584\u20131588.","DOI":"10.1016\/j.jacc.2008.05.065"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. New England Journal of Medicine. 2012; 367: 1287\u20131296.","DOI":"10.1056\/NEJMoa1208410"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. New England Journal of Medicine. 2017; 377: 2419\u20132432.","DOI":"10.1056\/NEJMoa1710261"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008; 117: 686\u2013697.","DOI":"10.1161\/CIRCULATIONAHA.106.613596"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Elbadawi A, Elgendy IY, Mahmoud K, Barakat AF, Mentias A, Mohamed AH, et al. Temporal Trends and Outcomes of Mechanical Complications in Patients with Acute Myocardial Infarction. JACC: Cardiovascular Interventions. 2019; 12: 1825\u20131836.","DOI":"10.1016\/j.jcin.2019.04.039"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Menon V, Webb JG, Hillis LD, Sleeper LA, Abboud R, Dzavik V, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries in cardiogenic shocK? Journal of the American College of Cardiology. 2000; 36: 1110\u20131116.","DOI":"10.1016\/S0735-1097(00)00878-0"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Alonso DR, Scheidt S, Post M, Killip T. Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations. Circulation. 1973; 48: 588\u2013596.","DOI":"10.1161\/01.CIR.48.3.588"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"McCallister BD, Christian TF, Gersh BJ, Gibbons RJ. Prognosis of myocardial infarctions involving more than 40% of the left ventricle after acute reperfusion therapy. Circulation. 1993; 88: 1470\u20131475.","DOI":"10.1161\/01.CIR.88.4.1470"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Archives of Internal Medicine. 2005; 165: 1643\u20131650.","DOI":"10.1001\/archinte.165.14.1643"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Prondzinsky R, Unverzagt S, Lemm H, Wegener N, Schlitt A, Heinroth KM, et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clinical Research in Cardiology. 2012; 101: 375\u2013384.","DOI":"10.1007\/s00392-011-0403-3"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003; 107: 2998\u20133002.","DOI":"10.1161\/01.CIR.0000075927.67673.F2"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016; 37: 2129\u20132200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Jones TL, Nakamura K, McCabe JM. Cardiogenic shock: evolving definitions and future directions in management. Open Heart. 2020; 6: e000960.","DOI":"10.1136\/openhrt-2018-000960"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Binder MJ, Ryan JA, Marcus S, Mugler F, Strange D, Agress CM. Evaluation of therapy in shock following acute myocardial infarction. American Journal of Medicine. 1955; 18: 622\u2013632.","DOI":"10.1016\/0002-9343(55)90463-0"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Hochman JS, Sleeper LA, Godfrey E, McKinlay SM, Sanborn T, Col J, et al. Should we Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK: an international randomized trial of emergency PTCA\/CABG\u2014trial design. American Heart Journal. 1999; 137: 313\u2013321.","DOI":"10.1053\/hj.1999.v137.95352"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Burkhoff D, Cohen H, Brunckhorst C, O\u2019Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. American Heart Journal. 2006; 152: 469.e1\u2013469.e8.","DOI":"10.1016\/j.ahj.2006.05.031"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Thiele H, Schuler G, Neumann F, Hausleiter J, Olbrich H, Schwarz B, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. American Heart Journal. 2012; 163: 938\u2013945.","DOI":"10.1016\/j.ahj.2012.03.012"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Thiele H, Desch S, Piek JJ, Stepinska J, Oldroyd K, Serpytis P, et al. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. American Heart Journal. 2016; 172: 160\u2013169.","DOI":"10.1016\/j.ahj.2015.11.006"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology. 2000; 36: 1071\u20131076.","DOI":"10.1016\/S0735-1097(00)00874-3"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018; 39: 119\u2013177.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Forrester JS, Diamond GA, Swan HJ. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. American Journal of Cardiology. 1977; 39: 137\u2013145.","DOI":"10.1016\/S0002-9149(77)80182-3"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Ng VG, Lansky AJ, Meller S, Witzenbichler B, Guagliumi G, Peruga JZ, et al. The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. European Heart Journal. Acute Cardiovascular Care. 2014; 3: 67\u201377.","DOI":"10.1177\/2048872613507149"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Brener MI, Rosenblum HR, Burkhoff D. Pathophysiology and Advanced Hemodynamic Assessment of Cardiogenic Shock. Methodist DeBakey Cardiovascular Journal. 2020; 16: 7\u201315.","DOI":"10.14797\/mdcj-16-1-7"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. Journal of the American College of Cardiology. 2003; 41: 1797\u20131804.","DOI":"10.1016\/S0735-1097(03)00309-7"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Stevenson LW. Design of therapy for advanced heart failure. European Journal of Heart Failure. 2005; 7: 323\u2013331.","DOI":"10.1016\/j.ejheart.2005.01.004"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Kapur NK, Thayer KL, Zweck E. Cardiogenic Shock in the Setting of Acute Myocardial Infarction. Methodist DeBakey Cardiovascular Journal. 2020; 16: 16\u201321.","DOI":"10.14797\/mdcj-16-1-16"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC\/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation. 2001; 104: 2996\u20133007.","DOI":"10.1161\/hc4901.102568"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. the Journal of Heart and Lung Transplantation. 2009; 28: 535\u2013541.","DOI":"10.1016\/j.healun.2009.02.015"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, et al. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit. Journal of the American College of Cardiology. 2019; 74: 2117\u20132128.","DOI":"10.1016\/j.jacc.2019.07.077"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Jentzer JC, Baran DA, van Diepen S, Barsness GW, Henry TD, Naidu SS, et al. Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patients. American Heart Journal. 2020; 219: 37\u201346.","DOI":"10.1016\/j.ahj.2019.10.012"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Hanson ID, Tagami T, Mando R, Kara Balla A, Dixon SR, Timmis S, et al. SCAI shock classification in acute myocardial infarction: Insights from the National Cardiogenic Shock Initiative. Catheterization and Cardiovascular Interventions. 2020; 96: 1137\u20131142.","DOI":"10.1002\/ccd.29139"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Baran DA, Long A, Badiye AP, Stelling K. Prospective validation of the SCAI shock classification: Single center analysis. Catheterization and Cardiovascular Interventions. 2020; 96: 1339\u20131347.","DOI":"10.1002\/ccd.29319"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez-Montfort J, Mahr C, et al. Invasive Hemodynamic Assessment and Classification of in-Hospital Mortality Risk among Patients with Cardiogenic Shock. Circulation: Heart Failure. 2020; 13: e007099.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Schrage B, Dabboura S, Yan I, Hilal R, Neumann JT, S\u00f6rensen NA, et al. Application of the SCAI classification in a cohort of patients with cardiogenic shock. Catheterization and Cardiovascular Interventions. 2020; 96: E213\u2013E219.","DOI":"10.1002\/ccd.28707"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Pareek N, Dworakowski R, Webb I, Barash J, Emezu G, Melikian N, et al. SCAI cardiogenic shock classification after out of hospital cardiac arrest and association with outcome. Catheterization and Cardiovascular Interventions. 2021; 97: E288\u2013E297.","DOI":"10.1002\/ccd.28984"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Califf RM, Bengtson JR. Cardiogenic shock. New England Journal of Medicine. 1994; 330: 1724\u20131730.","DOI":"10.1056\/NEJM199406163302406"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Saxena A, Garan AR, Kapur NK, O\u2019Neill WW, Lindenfeld J, Pinney SP, et al. Value of Hemodynamic Monitoring in Patients with Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation. 2020; 141: 1184\u20131197.","DOI":"10.1161\/CIRCULATIONAHA.119.043080"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Rossello X, Vila M, Rivas-Lasarte M, Ferrero-Gregori A, Sans-Rosell\u00f3 J, Duran-Cambra A, et al. Impact of Pulmonary Artery Catheter Use on Short- and Long-Term Mortality in Patients with Cardiogenic Shock. Cardiology. 2017; 136: 61\u201369.","DOI":"10.1159\/000448110"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Garan AR, Kanwar M, Thayer KL, Whitehead E, Zweck E, Hernandez-Montfort J, et al. Complete Hemodynamic Profiling with Pulmonary Artery Catheters in Cardiogenic Shock is Associated with Lower in-Hospital Mortality. JACC: Heart Failure. 2020; 8: 903\u2013913.","DOI":"10.1016\/j.jchf.2020.08.012"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Gore JM, Goldberg RJ, Spodick DH, Alpert JS, Dalen JE. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest. 1987; 92: 721\u2013727.","DOI":"10.1378\/chest.92.4.721"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Koo KKY, Sun JCJ, Zhou Q, Guyatt G, Cook DJ, Walter SD, et al. Pulmonary artery catheters: evolving rates and reasons for use. Critical Care Medicine. 2011; 39: 1613\u20131618.","DOI":"10.1097\/CCM.0b013e318218a045"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Vallabhajosyula S, Shankar A, Patlolla SH, Prasad A, Bell MR, Jentzer JC, et al. Pulmonary artery catheter use in acute myocardial infarction\u2010cardiogenic shock. ESC Heart Failure. 2020; 7: 1234\u20131245.","DOI":"10.1002\/ehf2.12652"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Shah MR, Hasselblad V, Stevenson LW, Binanay C, O\u2019Connor CM, Sopko G, et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. Journal of the American Medical Association. 2005; 294: 1664\u20131670.","DOI":"10.1001\/jama.294.13.1664"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Binanay C, Califf RM, Hasselblad V, O\u2019Connor CM, Shah MR, Sopko G, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. Journal of the American Medical Association. 2005; 294: 1625\u20131633.","DOI":"10.1001\/jama.294.13.1625"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. Journal of the American Medical Association. 2003; 290: 2713\u20132720.","DOI":"10.1001\/jama.290.20.2713"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Rhodes A, Cusack RJ, Newman PJ, Grounds RM, Bennett ED. A randomised, controlled trial of the pulmonary artery catheter in critically ill patients. Intensive Care Medicine. 2002; 28: 256\u2013264.","DOI":"10.1007\/s00134-002-1206-9"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Sionis A, Rivas-Lasarte M, Mebazaa A, Tarvasm\u00e4ki T, Sans-Rosell\u00f3 J, Tolppanen H, et al. Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results from the CardShock Study. Journal of Intensive Care Medicine. 2020; 35: 1426\u20131433.","DOI":"10.1177\/0885066619828959"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. New England Journal of Medicine. 1996; 335: 775\u2013782.","DOI":"10.1056\/NEJM199609123351103"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. New England Journal of Medicine. 1997; 337: 1118\u20131123.","DOI":"10.1056\/NEJM199710163371603"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Cohen MG, Kelly RV, Kong DF, Menon V, Shah M, Ferreira J, et al. Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials. American Journal of Medicine. 2005; 118: 482\u2013488.","DOI":"10.1016\/j.amjmed.2004.12.018"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Zion MM, Balkin J, Rosenmann D, Goldbourt U, Reicher-Reiss H, Kaplinsky E, et al. Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group. Chest. 1990; 98: 1331\u20131335.","DOI":"10.1378\/chest.98.6.1331"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Weil MH. The \u201cVIP\u201d approach to the bedside management of shock. Journal of the American Medical Association. 1969; 207: 337.","DOI":"10.1001\/jama.1969.03150150049010"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Squara P, Hollenberg S, Payen D. Reconsidering Vasopressors for Cardiogenic Shock. Chest. 2019; 156: 392\u2013401.","DOI":"10.1016\/j.chest.2019.03.020"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Hajjar LA, Teboul J. Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art. Critical Care. 2019; 23: 76.","DOI":"10.1186\/s13054-019-2368-y"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Kapur NK, Davila CD, Jumean MF. Integrating Interventional Cardiology and Heart Failure Management for Cardiogenic Shock. Interventional Cardiology Clinics. 2017; 6: 481\u2013485.","DOI":"10.1016\/j.iccl.2017.03.014"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. European Heart Journal. 2019; 40: 2671\u20132683.","DOI":"10.1093\/eurheartj\/ehz363"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Gamper G, Havel C, Arrich J, Losert H, Pace NL, M\u00fcllner M, et al. Vasopressors for hypotensive shock. Cochrane Database of Systematic Reviews. 2016; 2: CD003709.","DOI":"10.1002\/14651858.CD003709.pub4"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database of Systematic Reviews. 2018; 1: CD009669.","DOI":"10.1002\/14651858.CD009669.pub3"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Vahdatpour C, Collins D, Goldberg S. Cardiogenic Shock. Journal of the American Heart Association. 2019; 8: e011991","DOI":"10.1161\/JAHA.119.011991"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Kaddoura R, Elmoheen A, Badawy E, Eltawagny MF, Seif MA, Bashir K, et al. Vasoactive pharmacologic therapy in cardiogenic shock: a critical review. Journal of Drug Assessment. 2021; 10: 68\u201385.","DOI":"10.1080\/21556660.2021.1930548"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. New England Journal of Medicine. 2010; 362: 779\u2013789.","DOI":"10.1056\/NEJMoa0907118"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Levy B, Perez P, Perny J, Thivilier C, Gerard A. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Critical Care Medicine. 2011; 39: 450\u2013455.","DOI":"10.1097\/CCM.0b013e3181ffe0eb"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, et al. Epinephrine Versus Norepinephrine for Cardiogenic Shock after Acute Myocardial Infarction. Journal of the American College of Cardiology. 2018; 72: 173\u2013182.","DOI":"10.1016\/j.jacc.2018.04.051"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Gonz\u00e1lez MJ, Dom\u00ednguez-Rodr\u00edguez A, Ferrer-Hita JJ, Abreu-Gonz\u00e1lez P, Mu\u00f1oz MB. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. European Journal of Heart Failure. 2006; 8: 723\u2013728.","DOI":"10.1016\/j.ejheart.2006.01.007"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Dominguez-Rodriguez A, Samimi-Fard S, Garcia-Gonzalez MJ, Abreu-Gonzalez P. Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty. International Journal of Cardiology. 2008; 128: 214\u2013217.","DOI":"10.1016\/j.ijcard.2007.05.018"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Samimi-Fard S, Garc\u00eda-Gonz\u00e1lez MJ, Dom\u00ednguez-Rodr\u00edguez A, Abreu-Gonz\u00e1lez P. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty. International Journal of Cardiology. 2008; 127: 284\u2013287.","DOI":"10.1016\/j.ijcard.2007.04.143"},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Fuhrmann JT, Schmeisser A, Schulze MR, Wunderlich C, Schoen SP, Rauwolf T, et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Critical Care Medicine. 2008; 36: 2257\u20132266.","DOI":"10.1097\/CCM.0b013e3181809846"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Husebye T, Eritsland J, M\u00fcller C, Sandvik L, Arnesen H, Seljeflot I, et al. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study. European Journal of Heart Failure. 2013; 15: 565\u2013572.","DOI":"10.1093\/eurjhf\/hfs215"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, et al. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. New England Journal of Medicine. 2021; 385: 516\u2013525.","DOI":"10.1056\/NEJMoa2026845"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Cotter G, Kaluski E, Milo O, Blatt A, Salah A, Hendler A, et al. LINCS: L-NAME (a no synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. European Heart Journal. 2003; 24: 1287\u20131295.","DOI":"10.1016\/S0195-668X(03)00193-3"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Dzav\u00edk V, Cotter G, Reynolds HR, Alexander JH, Ramanathan K, Stebbins AL, et al. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. European Heart Journal. 2007; 28: 1109\u20131116.","DOI":"10.1093\/eurheartj\/ehm075"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. Journal of the American Medical Association. 2007; 297: 1657\u20131666.","DOI":"10.1001\/jama.297.15.joc70035"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clinical Trials. 1995; 16: 62\u201373.","DOI":"10.1016\/0197-2456(94)00031-W"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials. 1996; 17: 1\u201312.","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Clark HD, Wells GA, Hu\u00ebt C, McAlister FA, Salmi LR, Fergusson D, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Controlled Clinical Trials. 1999; 20: 448\u2013452.","DOI":"10.1016\/S0197-2456(99)00026-4"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Karami M, Hemradj VV, Ouweneel DM, den Uil CA, Limpens J, Otterspoor LC, et al. Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2020; 9: 2051.","DOI":"10.3390\/jcm9072051"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Burgos LM, Seoane L, Furmento JF, Costabel JP, Diez M, Vrancic M, et al. Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis. Perfusion. 2020; 35: 484\u2013491.","DOI":"10.1177\/0267659120918473"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Kaddoura R, Omar AS, Ibrahim MIM, Alkhulaifi A, Lorusso R, Elsherbini H, et al. Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis. Journal of Cardiothoracic and Vascular Anesthesia. 2021; 35: 2483\u20132495.","DOI":"10.1053\/j.jvca.2021.01.019"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"Patel SJ, Augoustides JG. Levosimendan and Venoarterial ECMO\u2014a Promising Application. Journal of Cardiothoracic and Vascular Anesthesia. 2021; 35: 2496\u20132498.","DOI":"10.1053\/j.jvca.2021.03.052"},{"key":"ref116","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127: e362\u2013e425."},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128: e240\u2013e327.","DOI":"10.1161\/CIR.0b013e31829e8776"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019; 40: 87\u2013165.","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"Guerrero-Miranda CY, Hall SA. Cardiogenic Shock in Patients with Advanced Chronic Heart Failure. Methodist DeBakey Cardiovascular Journal. 2020; 16: 22\u201326.","DOI":"10.14797\/mdcj-16-1-22"},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI\/ACC\/HFSA\/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d\u2019intervention. Journal of the American College of Cardiology. 2015; 65: e7\u2013e26.","DOI":"10.1002\/ccd.25720"},{"key":"ref121","doi-asserted-by":"crossref","unstructured":"Masoudi FA, Ponirakis A, de Lemos JA, Jollis JG, Kremers M, Messenger JC, et al. Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries. Journal of the American College of Cardiology. 2017; 69: 1427\u20131450.","DOI":"10.1016\/j.jacc.2016.12.005"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"Moulopoulos S, Stamatelopoulos S, Petrou P. Intraaortic balloon assistance in intractable cardiogenic shock. European Heart Journal. 1986; 7: 396\u2013403.","DOI":"10.1093\/oxfordjournals.eurheartj.a062080"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. the Annals of Thoracic Surgery. 2004; 77: 1642\u20131647.","DOI":"10.1016\/j.athoracsur.2003.10.013"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Thiele H, Sick P, Boudriot E, Diederich K, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. European Heart Journal. 2005; 26: 1276\u20131283.","DOI":"10.1093\/eurheartj\/ehi161"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LSD, van Domburg RT, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. European Heart Journal. 2009; 30: 2102\u20132108.","DOI":"10.1093\/eurheartj\/ehp292"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"Thiele H, Jobs A, Ouweneel DM, Henriques JPS, Seyfarth M, Desch S, et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. European Heart Journal. 2017; 38: 3523\u20133531.","DOI":"10.1093\/eurheartj\/ehx363"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Roffi M, Patrono C, Collet J, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal. 2016; 37: 267\u2013315.","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020; 396: 199\u2013212.","DOI":"10.1016\/S0140-6736(20)31047-3"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Hsu P, Parker J, Egger C, Autschbach R, Schmitz-Rode T, Steinseifer U. Mechanical circulatory support for right heart failure: current technology and future outlook. Artificial Organs. 2012; 36: 332\u2013347.","DOI":"10.1111\/j.1525-1594.2011.01366.x"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382: 1638\u20131645.","DOI":"10.1016\/S0140-6736(13)61783-3"},{"key":"ref131","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Thelemann N, Neumann FJ, Hausleiter J, Abdel-Wahab M, et al. Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial. Circulation 2019; 139: 395\u2013403.","DOI":"10.1161\/CIRCULATIONAHA.118.038201"},{"key":"ref132","doi-asserted-by":"crossref","unstructured":"Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. the Journal of Heart and Lung Transplantation. 2015; 34: 1549\u20131560.","DOI":"10.1016\/j.healun.2015.08.018"},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"Kapur NK, Esposito ML, Bader Y, Morine KJ, Kiernan MS, Pham DT, et al. Mechanical Circulatory Support Devices for Acute Right Ventricular Failure. Circulation. 2017; 136: 314\u2013326.","DOI":"10.1161\/CIRCULATIONAHA.116.025290"},{"key":"ref134","unstructured":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Bl\u00f6mstrom-Lundqvist C, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2012; 33: 2569\u20132619."},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. American Heart Journal. 2001; 141: 933\u2013939.","DOI":"10.1067\/mhj.2001.115295"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R, et al. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI. EuroIntervention. 2011; 7: 437\u2013441.","DOI":"10.4244\/EIJV7I4A72"},{"key":"ref137","doi-asserted-by":"crossref","unstructured":"Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM. Use and Effectiveness of Intra-Aortic Balloon Pumps among Patients Undergoing High Risk Percutaneous Coronary Intervention: Insights from the National Cardiovascular Data Registry. Circulation: Cardiovascular Quality and Outcomes. 2012; 5: 21\u201330.","DOI":"10.1161\/CIRCOUTCOMES.110.960385"},{"key":"ref138","doi-asserted-by":"crossref","unstructured":"Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DWT, O\u2019Dea D, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. Journal of Thrombosis and Thrombolysis. 2005; 19: 33\u201339.","DOI":"10.1007\/s11239-005-0938-0"},{"key":"ref139","doi-asserted-by":"crossref","unstructured":"Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Critical Care Medicine. 2010; 38: 152\u2013160.","DOI":"10.1097\/CCM.0b013e3181b78671"},{"key":"ref140","doi-asserted-by":"crossref","unstructured":"Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, et a. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. Journal of the American Medical Association. 2010; 304: 867\u2013874.","DOI":"10.1001\/jama.2010.1190"},{"key":"ref141","doi-asserted-by":"crossref","unstructured":"Sjauw KD, Engstr\u00f6m AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? European Heart Journal. 2009; 30: 459\u2013468.","DOI":"10.1093\/eurheartj\/ehn602"},{"key":"ref142","doi-asserted-by":"crossref","unstructured":"Romeo F, Acconcia MC, Sergi D, Romeo A, Muscoli S, Valente S, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. American Heart Journal. 2013; 165: 679\u2013692.","DOI":"10.1016\/j.ahj.2013.02.020"},{"key":"ref143","doi-asserted-by":"crossref","unstructured":"Unverzagt S, Buerke M, de Waha A, Haerting J, Pietzner D, Seyfarth M, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database of Systematic Reviews. 2015; 3: CD007398.","DOI":"10.1002\/14651858.CD007398.pub3"},{"key":"ref144","doi-asserted-by":"crossref","unstructured":"Ahmad Y, Sen S, Shun-Shin MJ, Ouyang J, Finegold JA, Al-Lamee RK, et al. Intra-aortic Balloon Pump Therapy for Acute Myocardial Infarction: a Meta-analysis. JAMA Internal Medicine. 2015; 175: 931\u2013939.","DOI":"10.1001\/jamainternmed.2015.0569"},{"key":"ref145","doi-asserted-by":"crossref","unstructured":"Lauten A, Engstr\u00f6m AE, Jung C, Empen K, Erne P, Cook S, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circulation. Heart Failure. 2013; 6: 23\u201330.","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224"},{"key":"ref146","doi-asserted-by":"crossref","unstructured":"Ouweneel DM, Eriksen E, Seyfarth M, Henriques JPS. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump for Treating Cardiogenic Shock: Meta-Analysis. Journal of the American College of Cardiology. 2017; 69: 358\u2013360.","DOI":"10.1016\/j.jacc.2016.10.026"},{"key":"ref147","doi-asserted-by":"crossref","unstructured":"Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, et al. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump with in-Hospital Mortality and Major Bleeding among Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock. Journal of the American Medical Association. 2020; 323: 734.","DOI":"10.1001\/jama.2020.0254"},{"key":"ref148","doi-asserted-by":"crossref","unstructured":"O\u2019Neill WW, Schreiber T, Wohns DHW, Rihal C, Naidu SS, Civitello AB, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. Journal of Interventional Cardiology. 2014; 27: 1\u201311.","DOI":"10.1111\/joic.12080"},{"key":"ref149","doi-asserted-by":"crossref","unstructured":"Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheterization and Cardiovascular Interventions. 2018; 91: 454\u2013461.","DOI":"10.1002\/ccd.27427"},{"key":"ref150","doi-asserted-by":"crossref","unstructured":"Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, et al. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation. 2019; 139: 1249\u20131258.","DOI":"10.1161\/CIRCULATIONAHA.118.036614"},{"key":"ref151","unstructured":"Valgimigli M, Steendijk P, Serruys PW, Vranckx P, Boomsma F, Onderwater E, et al. Use of Impella Recover(R) LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings. EuroIntervention. 2006; 2: 91\u2013100."},{"key":"ref152","doi-asserted-by":"crossref","unstructured":"Dixon SR, Henriques JPS, Mauri L, Sjauw K, Civitello A, Kar B, et al. A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (the PROTECT I Trial). JACC: Cardiovascular Interventions. 2009; 2: 91\u201396.","DOI":"10.1016\/j.jcin.2008.11.005"},{"key":"ref153","doi-asserted-by":"crossref","unstructured":"Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, et al. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheterization and Cardiovascular Interventions. 2012; 80: 717\u2013725.","DOI":"10.1002\/ccd.23403"},{"key":"ref154","doi-asserted-by":"crossref","unstructured":"O\u2019Neill WW, Kleiman NS, Moses J, Henriques JPS, Dixon S, Massaro J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012; 126: 1717\u20131727.","DOI":"10.1161\/CIRCULATIONAHA.112.098194"},{"key":"ref155","doi-asserted-by":"crossref","unstructured":"Dangas GD, Kini AS, Sharma SK, Henriques JPS, Claessen BE, Dixon SR, et al. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). American Journal of Cardiology. 2014; 113: 222\u2013228.","DOI":"10.1016\/j.amjcard.2013.09.008"},{"key":"ref156","doi-asserted-by":"crossref","unstructured":"Cohen MG, Ghatak A, Kleiman NS, Naidu SS, Massaro JM, Kirtane AJ, et al. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT \u0399\u0399 study. Catheterization and Cardiovascular Interventions. 2014; 83: 1057\u20131064.","DOI":"10.1002\/ccd.25277"},{"key":"ref157","doi-asserted-by":"crossref","unstructured":"Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. Journal of the American College of Cardiology. 2011; 57: 688\u2013696.","DOI":"10.1016\/j.jacc.2010.08.613"},{"key":"ref158","unstructured":"Thomas JL, Al-Ameri H, Economides C, Shareghi S, Abad DG, Mayeda G, et al. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock. Journal of Invasive Cardiology. 2010; 22: 360\u2013364."},{"key":"ref159","unstructured":"Bagai J, Webb D, Kasasbeh E, Crenshaw M, Salloum J, Chen J, et al. Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest. Journal of Invasive Cardiology. 2011; 23: 141\u2013147."},{"key":"ref160","doi-asserted-by":"crossref","unstructured":"Alli OO, Singh IM, Holmes DR, Pulido JN, Park SJ, Rihal CS. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience. Catheterization and Cardiovascular Interventions. 2012; 80: 728\u2013734.","DOI":"10.1002\/ccd.23465"},{"key":"ref161","doi-asserted-by":"crossref","unstructured":"Zavalichi MA, Nistor I, Nedelcu A, Zavalichi SD, Georgescu CMA, St\u0103tescu C, et al. Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: a Systematic Review. BioMed Research International. 2020; 2020: 1\u20139.","DOI":"10.1155\/2020\/6126534"},{"key":"ref162","doi-asserted-by":"crossref","unstructured":"Muller G, Flecher E, Lebreton G, Luyt C, Trouillet J, Br\u00e9chot N, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Medicine. 2016; 42: 370\u2013378.","DOI":"10.1007\/s00134-016-4223-9"},{"key":"ref163","doi-asserted-by":"crossref","unstructured":"Banning AS, Adriaenssens T, Berry C, Bogaerts K, Erglis A, Distelmaier K, et al. Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial. EuroIntervention. 2021; 16: e1227\u2013e1236.","DOI":"10.4244\/EIJ-D-20-01076"},{"key":"ref164","doi-asserted-by":"crossref","unstructured":"Sakamoto S, Taniguchi N, Nakajima S, Takahashi A. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. Annals of Thoracic Surgery. 2012; 94: 1\u20137.","DOI":"10.1016\/j.athoracsur.2012.01.032"},{"key":"ref165","doi-asserted-by":"crossref","unstructured":"Kim H, Lim S, Hong J, Hong Y, Lee CJ, Jung J, et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation. 2012; 83: 971\u2013975.","DOI":"10.1016\/j.resuscitation.2012.01.037"},{"key":"ref166","doi-asserted-by":"crossref","unstructured":"Xie A, Phan K, Tsai Y, Yan TD, Forrest P. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis. Journal of Cardiothoracic and Vascular Anesthesia. 2015; 29: 637\u2013645.","DOI":"10.1053\/j.jvca.2014.09.005"},{"key":"ref167","doi-asserted-by":"crossref","unstructured":"Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engstr\u00f6m AE, Lagrand WK, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Medicine. 2016; 42: 1922\u20131934.","DOI":"10.1007\/s00134-016-4536-8"},{"key":"ref168","doi-asserted-by":"crossref","unstructured":"Chen Y, Chao A, Yu H, Ko W, Wu I, Chen RJ, et al. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. Journal of the American College of Cardiology. 2003; 41: 197\u2013203.","DOI":"10.1016\/S0735-1097(02)02716-X"},{"key":"ref169","doi-asserted-by":"crossref","unstructured":"Chen Y, Lin J, Yu H, Ko W, Jerng J, Chang W, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008; 372: 554\u2013561.","DOI":"10.1016\/S0140-6736(08)60958-7"},{"key":"ref170","doi-asserted-by":"crossref","unstructured":"Thiagarajan RR, Brogan TV, Scheurer MA, Laussen PC, Rycus PT, Bratton SL. Extracorporeal Membrane Oxygenation to Support Cardiopulmonary Resuscitation in Adults. Annals of Thoracic Surgery. 2009; 87: 778\u2013785.","DOI":"10.1016\/j.athoracsur.2008.12.079"},{"key":"ref171","doi-asserted-by":"crossref","unstructured":"Kagawa E, Dote K, Kato M, Sasaki S, Nakano Y, Kajikawa M, et al. Should we emergently revascularize occluded coronaries for cardiac arrest?: rapid-response extracorporeal membrane oxygenation and intra-arrest percutaneous coronary intervention. Circulation. 2012; 126: 1605\u20131613.","DOI":"10.1161\/CIRCULATIONAHA.111.067538"},{"key":"ref172","doi-asserted-by":"crossref","unstructured":"Maxhera B, Albert A, Ansari E, Godehardt E, Lichtenberg A, Saeed D. Survival predictors in ventricular assist device patients with prior extracorporeal life support: selecting appropriate candidates. Artificial Organs. 2014; 38: 727\u2013732.","DOI":"10.1111\/aor.12386"},{"key":"ref173","doi-asserted-by":"crossref","unstructured":"Aso S, Matsui H, Fushimi K, Yasunaga H. The Effect of Intraaortic Balloon Pumping under Venoarterial Extracorporeal Membrane Oxygenation on Mortality of Cardiogenic Patients: an Analysis Using a Nationwide Inpatient Database. Critical Care Medicine. 2016; 44: 1974\u20131979.","DOI":"10.1097\/CCM.0000000000001828"},{"key":"ref174","doi-asserted-by":"crossref","unstructured":"Mandawat A, Rao SV. Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock. Circulation. Cardiovascular Interventions. 2018; 10: e004337.","DOI":"10.1161\/CIRCINTERVENTIONS.116.004337"},{"key":"ref175","doi-asserted-by":"crossref","unstructured":"John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. Journal of Thoracic and Cardiovascular Surgery. 2011; 141: 932\u2013939.","DOI":"10.1016\/j.jtcvs.2010.03.046"},{"key":"ref176","doi-asserted-by":"crossref","unstructured":"Kapur NK, Paruchuri V, Jagannathan A, Steinberg D, Chakrabarti AK, Pinto D, et al. Mechanical circulatory support for right ventricular failure. JACC: Heart Failure. 2013; 1: 127\u2013134.","DOI":"10.1016\/j.jchf.2013.01.007"},{"key":"ref177","doi-asserted-by":"crossref","unstructured":"Takayama H, Truby L, Koekort M, Uriel N, Colombo P, Mancini DM, et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. Journal of Heart and Lung Transplantation. 2013; 32: 106\u2013111.","DOI":"10.1016\/j.healun.2012.10.005"},{"key":"ref178","doi-asserted-by":"crossref","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2020; 42: 1289\u20131367.","DOI":"10.1093\/eurheartj\/ehaa909"},{"key":"ref179","doi-asserted-by":"crossref","unstructured":"Berger PB, Holmes DR, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation. 1997; 96: 122\u2013127.","DOI":"10.1161\/01.CIR.96.1.122"},{"key":"ref180","doi-asserted-by":"crossref","unstructured":"French JK, Feldman HA, Assmann SF, Sanborn T, Palmeri ST, Miller D, et al. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. American Heart Journal. 2003; 146: 804\u2013810.","DOI":"10.1016\/S0002-8703(03)00392-2"},{"key":"ref181","doi-asserted-by":"crossref","unstructured":"Col NF, Gurwitz JH, Alpert JS, Goldberg RJ. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. American Journal of Cardiology. 1994; 73: 149\u2013157.","DOI":"10.1016\/0002-9149(94)90206-2"},{"key":"ref182","doi-asserted-by":"crossref","unstructured":"Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction. Journal of the American Medical Association. 2006; 295: 2511.","DOI":"10.1001\/jama.295.21.2511"},{"key":"ref183","doi-asserted-by":"crossref","unstructured":"Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, et al. One-Year Outcomes after PCI Strategies in Cardiogenic Shock. New England Journal of Medicine. 2018; 379: 1699\u20131710.","DOI":"10.1056\/NEJMoa1808788"},{"key":"ref184","doi-asserted-by":"crossref","unstructured":"Tarantini G, D\u2019Amico G, Tellaroli P, Colombo C, Brener SJ. Meta-Analysis of the Optimal Percutaneous Revascularization Strategy in Patients with Acute Myocardial Infarction, Cardiogenic Shock, and Multivessel Coronary Artery Disease. American Journal of Cardiology. 2017; 119: 1525\u20131531.","DOI":"10.1016\/j.amjcard.2017.02.028"},{"key":"ref185","doi-asserted-by":"crossref","unstructured":"de Waha S, Jobs A, Eitel I, P\u00f6ss J, Stiermaier T, Meyer-Saraei R, et al. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: a systematic review and meta-analysis. European Heart Journal Acute Cardiovascular Care. 2018; 7: 28\u201337.","DOI":"10.1177\/2048872617719640"},{"key":"ref186","doi-asserted-by":"crossref","unstructured":"Kolte D, Sardar P, Khera S, Zeymer U, Thiele H, Hochadel M, et al. Culprit Vessel-only Versus Multivessel Percutaneous Coronary Intervention in Patients with Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: a Collaborative Meta-Analysis. Circulation: Cardiovascular Interventions. 2017; 10: e005582.","DOI":"10.1161\/CIRCINTERVENTIONS.117.005582"},{"key":"ref187","doi-asserted-by":"crossref","unstructured":"Bertaina M, Ferraro I, Omed\u00e8 P, Conrotto F, Saint-Hilary G, Cavender MA, et al. Meta-Analysis Comparing Complete or Culprit only Revascularization in Patients with Multivessel Disease Presenting with Cardiogenic Shock. American Journal of Cardiology. 2018; 122: 1661\u20131669.","DOI":"10.1016\/j.amjcard.2018.08.003"},{"key":"ref188","doi-asserted-by":"crossref","unstructured":"Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. New England Journal of Medicine. 2019; 381: 1411\u20131421.","DOI":"10.1056\/NEJMoa1907775"},{"key":"ref189","doi-asserted-by":"crossref","unstructured":"Marquis\u2010Gravel G, Zeitouni M, Kochar A, Jones WS, Sketch MH, Rao SV, et al. Technical consideration in acute myocardial infarction with cardiogenic shock: a review of antithrombotic and PCI therapies. Catheterization and Cardiovascular Interventions. 2020; 95: 924\u2013931.","DOI":"10.1002\/ccd.28455"},{"key":"ref190","doi-asserted-by":"crossref","unstructured":"Mason PJ, Shah B, Tamis-Holland JE, Bittl JA, Cohen MG, Safirstein J, et al. An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: a Scientific Statement from the American Heart Association. Circulation: Cardiovascular Interventions. 2018; 11: e000035.","DOI":"10.1161\/HCV.0000000000000035"},{"key":"ref191","doi-asserted-by":"crossref","unstructured":"Mamas MA, Anderson SG, Ratib K, Routledge H, Neyses L, Fraser DG, et al. Arterial access site utilization in cardiogenic shock in the United Kingdom: is radial access feasible? American Heart Journal. 2014; 167: 900\u20138.e1.","DOI":"10.1016\/j.ahj.2014.03.007"},{"key":"ref192","doi-asserted-by":"crossref","unstructured":"Pancholy SB, Palamaner Subash Shantha G, Romagnoli E, Kedev S, Bernat I, Rao SV, et al. Impact of access site choice on outcomes of patients with cardiogenic shock undergoing percutaneous coronary intervention: a systematic review and meta-analysis. American Heart Journal. 2015; 170: 353\u2013361.","DOI":"10.1016\/j.ahj.2015.05.001"},{"key":"ref193","doi-asserted-by":"crossref","unstructured":"Rashid M, Rushton CA, Kwok CS, Kinnaird T, Kontopantelis E, Olier I, et al. Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: an Insight from the British Cardiovascular Intervention Society Dataset. JACC: Cardiovascular Interventions. 2017; 10: 2258\u20132265.","DOI":"10.1016\/j.jcin.2017.07.049"},{"key":"ref194","doi-asserted-by":"crossref","unstructured":"Champion S, Ga\u00fcz\u00e8re BA, Lefor Y. Drug-eluting stents should not be used in ST-elevated myocardial infarction with cardiogenic shock. Archives of Internal Medicine. 2012; 172: 1613\u20131614.","DOI":"10.1001\/archinternmed.2012.4418"},{"key":"ref195","doi-asserted-by":"crossref","unstructured":"Ledwoch J, Fuernau G, Desch S, Eitel I, Jung C, de Waha S, et al. Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock. Heart. 2017; 103: 1177\u20131184.","DOI":"10.1136\/heartjnl-2016-310403"},{"key":"ref196","doi-asserted-by":"crossref","unstructured":"Chen D, Mao C, Tsai M, Chen S, Lin Y, Hsieh I, et al. Clinical outcomes of drug-eluting stents versus bare-metal stents in patients with cardiogenic shock complicating acute myocardial infarction. International Journal of Cardiology. 2016; 215: 98\u2013104.","DOI":"10.1016\/j.ijcard.2016.04.014"},{"key":"ref197","doi-asserted-by":"crossref","unstructured":"P\u00f6ss J, K\u00f6ster J, Fuernau G, Eitel I, de Waha S, Ouarrak T, et al. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction. Journal of the American College of Cardiology. 2017; 69: 1913\u20131920.","DOI":"10.1016\/j.jacc.2017.02.027"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/3\/10.31083\/j.rcm2203078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:20:06Z","timestamp":1732728006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/3\/10.31083\/j.rcm2203078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":197,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["1632453066277-1010099056"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2203078","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"691"}}